Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 10983846)

Published in Life Sci on August 11, 2000

Authors

N D Volkow1, G J Wang, M W Fischman, R Foltin, J S Fowler, D Franceschi, M Franceschi, J Logan, S J Gatley, C Wong, Y S Ding, R Hitzemann, N Pappas

Author Affiliations

1: Medical Department, Upton, NY 11973, USA. volkow@bnl.gov

Articles citing this

Imaging dopamine's role in drug abuse and addiction. Neuropharmacology (2008) 3.28

Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A (2011) 2.62

Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol (2011) 2.51

Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays (2010) 1.97

Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci (2008) 1.97

Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry (2011) 1.53

Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception. Psychiatry Res (2007) 1.44

Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine. Neuroimage (2008) 1.30

Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav (2006) 1.28

Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis (2012) 1.25

Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav (2008) 1.17

Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse. AAPS J (2006) 1.12

Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care (2011) 1.09

Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04

Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans. Eur J Pharmacol (2010) 1.03

Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochem Pharmacol (2011) 1.01

Early and prolonged exposure to reward delay: effects on impulsive choice and alcohol self-administration in male rats. Exp Clin Psychopharmacol (2013) 0.96

Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D1 over D2 receptor signaling. J Neurosci (2013) 0.94

Route of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusion. J Mol Neurosci (2010) 0.92

The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats. Pharmacol Biochem Behav (2008) 0.92

Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses. Physiol Behav (2012) 0.91

Increasing the incentive salience of cocaine challenges preference for pup- over cocaine-associated stimuli during early postpartum: place preference and locomotor analyses in the lactating female rat. Psychopharmacology (Berl) (2007) 0.91

Investigation of "bath salts" use patterns within an online sample of users in the United States. J Psychoactive Drugs (2014) 0.90

Mechanisms of acute cocaine toxicity. Open Pharmacol J (2008) 0.88

Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates. Pharmacol Biochem Behav (2010) 0.87

Monoamine transporters: vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci (2011) 0.87

Developing a vaccine against multiple psychoactive targets: a case study of heroin. CNS Neurol Disord Drug Targets (2011) 0.87

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. Subst Abuse Rehabil (2013) 0.85

Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction. Ann N Y Acad Sci (2008) 0.84

Neuroimaging and drug taking in primates. Psychopharmacology (Berl) (2011) 0.83

Rapid delivery of cocaine facilitates acquisition of self-administration in rats: an effect masked by paired stimuli. Pharmacol Biochem Behav (2011) 0.82

Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line. Br J Pharmacol (2015) 0.80

Neuroticism associated with cocaine-induced psychosis in cocaine-dependent patients: a cross-sectional observational study. PLoS One (2014) 0.80

Impulsive choice, alcohol consumption, and pre-exposure to delayed rewards: II. Potential mechanisms. J Exp Anal Behav (2014) 0.79

Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability. Int J Neuropsychopharmacol (2014) 0.79

Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. J Clin Psychopharmacol (2016) 0.78

Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose. Pharmacol Biochem Behav (2008) 0.77

Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules. Hum Psychopharmacol (2014) 0.77

Vaccines in the Treatment of Substance Abuse. Focus (Am Psychiatr Publ) (2011) 0.76

Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. J Psychopharmacol (2016) 0.76

Smokers versus snorters: do treatment outcomes differ according to route of cocaine administration? Exp Clin Psychopharmacol (2013) 0.76

Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration. Neurosci Lett (2010) 0.76

Reinforcing Doses of Intravenous Cocaine Produce Only Modest Dopamine Uptake Inhibition. ACS Chem Neurosci (2016) 0.76

The effects of oral d-amphetamine on impulsivity in smoked and intranasal cocaine users. Drug Alcohol Depend (2016) 0.75

Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies. J Addict Res Ther (2016) 0.75

CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction. Neuropsychopharmacology (2016) 0.75

The effect of crack cocaine addiction and age on the microstructure and morphology of the human striatum and thalamus using shape analysis and fast diffusion kurtosis imaging. Transl Psychiatry (2017) 0.75

Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes. PLoS One (2013) 0.75

Articles by these authors

Mutation of human short tandem repeats. Hum Mol Genet (1993) 14.03

Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab (1996) 9.49

Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (1997) 8.24

Brain dopamine and obesity. Lancet (2001) 8.00

Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol (1995) 7.86

Junior doctors' hours. Members of Junior Doctors Committee are in cloud cuckoo land. BMJ (1995) 7.84

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62

Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01

Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82

Optical coherence tomography of macular holes. Ophthalmology (1995) 4.64

Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex (2000) 4.61

A study of the quality of life and cost-utility of renal transplantation. Kidney Int (1996) 4.51

Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol (1995) 4.47

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13

The relationship of the spleen to the formation of the blood corpuscles. J Physiol (1902) 3.98

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry (2004) 3.80

Three-dimensional structure of rotavirus. J Mol Biol (1988) 3.79

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature (1997) 3.76

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46

The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol (1986) 3.36

Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29

Imaging dopamine's role in drug abuse and addiction. Neuropharmacology (2008) 3.28

Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25

Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci U S A (1984) 3.11

Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02

Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94

Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 2.89

The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85

White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2002) 2.72

Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet (1995) 2.62

Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 2.62

p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev (1999) 2.58

Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry (1999) 2.50

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry (1998) 2.50

Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry (1999) 2.49

The pharmacology of cocaine related to its abuse. Pharmacol Rev (1989) 2.49

Pinhole SPECT: an approach to in vivo high resolution SPECT imaging in small laboratory animals. J Nucl Med (1994) 2.42

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci (2001) 2.41